A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy

por McKiernan, James, Noerholm, Mikkel, Tadigotla, Vasisht, Kumar, Sonia, Torkler, Phillipp, Sant, Grannum, Alter, Jason, Donovan, Michael J., Skog, Johan
Publicado 2020

Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome

por Kretschmer, Alexander, Tutrone, Ronald, Alter, Jason, Berg, Elena, Fischer, Christian, Kumar, Sonia, Torkler, Phillipp, Tadigotla, Vasisht, Donovan, Michael, Sant, Grannum, Skog, Johan, Noerholm, Mikkel
Publicado 2022

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis

por Tutrone, Ronald, Lowentritt, Ben, Neuman, Brian, Donovan, Michael J., Hallmark, Elliot, Cole, T. Jeffrey, Yao, Yiyuan, Biesecker, Claire, Kumar, Sonia, Verma, Vinita, Sant, Grannum R., Alter, Jason, Skog, Johan
Publicado 2023

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy

por Kretschmer, Alexander, Kajau, Holger, Margolis, Eric, Tutrone, Ronald, Grimm, Tobias, Trottmann, Matthias, Stief, Christian, Stoll, Georg, Fischer, Christian A., Flinspach, Claudia, Albrecht, Anja, Meyer, Lisa, Priewasser, Tina, Enderle, Daniel, Müller, Romy, Torkler, Phillipp, Alter, Jason, Skog, Johan, Noerholm, Mikkel
Publicado 2022